Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Blogs

Gene therapy market is projected to be worth USD 14.6 billion in 2030 *Roots Analysis*

Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth, till 2030   Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings.   Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical develo

“Global Psychedelic Therapeutics Market, 2020-2030” <Roots Analysis>

To order this detailed 380+ page report, please visit this -https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html   Key Inclusions §  A detailed assessment of the current market landscape of psychedelic therapeutics, providing information on phase of development (commercial, clinical, preclinical, and discovery stage) of lead candidates, type of psychedelic substance, origin of psychedelic substance, target therapeutic area route of administration (intr

Evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, <Roots Analysis>

Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances. Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implic

Global Psychedelic therapeutics market is projected to grow at an annualized rate of ~15% <till 2030>

Roots Analysis has done a detailed study on Global Psychedelic Therapeutics Market, 2020-2030” covering key aspects of the industry and identifying potential future growth opportunities     To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this- https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html    Key Market Insights §  Nearly 70 players from across the world presently claim to be engaged in t

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030 *Roots Analysis*

A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders   Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.   The report features an extensive study of the current market landscape, offering an informed opinion on the like

“Neoantigen Targeted Therapies Market, 2019-2030” <Roots Analysis>

To order this detailed 320+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html   Key Inclusions §  A detailed assessment of the current market landscape, providing information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, type of molecule (small molecule and biologic), type of treatment (personalized and off-the-shelf),

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications <Roots Analysis>

The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are being investigated both as monotherapies and in combination with various immune checkpoint inhibitors, such as atezolizumab, durvalumab, ipilimumab, and nivolumab. Of these, certain pipeline candidates have already entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.   To ord

Neoantigen targeted therapies market is projected to grow at an annualized rate of 57%, <till 2030>

Roots Analysis has done a detailed study on Neoantigen Targeted Therapies, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 320+ page report, which features 110+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html   Key Market Insights §  Presently, over 150 neoantigen targeted therapies a

The neoantigen targeted therapies , <predicts Roots Analysis>

Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential   London   Roots Analysis is pleased to announce the publication of its recent study, titled, “Neoantigen Targeted Therapies, 2019-2030.”   The report features an extensive study of the current market landscape, offering an info

Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, growing at an annualized rate of 57% <Roots Analysis >

Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential   London   Roots Analysis has announced the addition of “Neoantigen Targeted Therapies, 2019-2030” report to its list of offerings.   The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell media

“Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030”

To order this detailed 200+ page report, please visit this - https://www.rootsanalysis.com/reports/human-factors-engineering-and-usability-testing-services.html   Key Inclusions §  A detailed assessment of the current market landscape of companies offering HFE and usability testing services based on several relevant parameters, including developer information (year of establishment, company size and location of headquarters), types of certifications obtained, types of HFE services

More than 90 companies claim to offer human factors engineering and usability testing services {Roots Analysis)

Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers   To order this 200+ page report, which features 120+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/human-factors-engineering-and-usability-testing-services.html   The USD 1 Billion (by 2030) financial op

The human factors engineering and usability testing service providers market <Roots Analysis>

Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers   Roots Analysis has announced the addition of “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030”” report to its list of offerings   The report features an extensive study on the current market l

The human factors engineering and usability testing services market to reach USD 1 Billion by 2030 <Roots Analysis >

Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers   London   Roots Analysis has announced the addition of “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030” report to its list of offerings.   Given the growing regulatory stringency, t

“Cell and Advanced Therapies Supply Chain Management Market, 2020-2030”

To order this 510+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html   Key Inclusions §  A detailed assessment of the current market landscape, featuring a comprehensive list of over 160 technological platforms that are being used to manage the cell and advanced therapies supply chain, along with information on the different types of software systems (COP, EMS, IMS, LIMS, LMS, PMS, QMS, TTS, and others), their

Presently, over 160 innovative, software enabled systems are being used to efficiently manage and streamline

The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.   To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this - htt

Given the cost saving potential across different processes and operations, projected to grow at an annualized rate of ~25% rapid <till 2030>

Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking & Tracing Systems, and Other Software), 2019-2030, covering key aspects of the industry’s evolution and identifying potential

“Medical Device Batteries: Focus on Implants and Wearable Medical Devices - Market Distribution by Battery”

To order this detailed 190+ page report, please visit this - https://www.rootsanalysis.com/reports/medical-device-batteries-market.html   Key Inclusions §  An overview of the current market landscape of medical device batteries, along with information on key product specifications, such as battery chemistry (lithium based,  zinc air based, silver oxide based, alkaline based, nickel based and hydrogen gas based), voltage (less than 3V, 3V to 6V, more than 6V), capacity (less than 6

The medical device batteries market is estimated to be worth USD 3.10 billion in 2030 (Roots Analysis)

Batteries play an important role in the overall performance and safety of many modern healthcare solutions; as more hand-held and point-of-care medical devices are introduced, the corresponding need for reliable power sources is also on the rise   Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device Batteries: Focus on Implants and Wearable Medical Devices - Market Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others), Re

The medical device batteries market is projected to grow at an annualized rate of 12%, <Roots Analysis>

An exponential increase in development efforts related to wearable medical devices and implants, has fueled a corresponding rise in demand for safe, compact, light-weight and high energy density batteries with longer life span   Roots Analysis has announced the addition of “Medical Device Batteries: Focus on Implants and Wearable Medical Devices - Market Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others), Rechargeability (Rechargeable and Non-Rechargeable), Applic

“Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030” (Roots Analysis)

To order this detailed 370+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html   Key Inclusions §  A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease indications being investigated, based on trial registration year, phase of development, recruitment s

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers (Roots Analysis)

Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.   To order this 370+ page report, which features 190+ figures and 180+ tables

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18% (till 2030)

Roots Analysis has done a detailed study on Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.” covering key aspects of the industry and identifying key future growth opportunities.   To order this 370+ page report, which features 190+ figures and 180+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html   Key Market Insights §  Seve
×
  • Create New...